Soft Tissue Sarcoma Market Set for Significant Growth at a CAGR of 7.9% During the Forecast Period (2026-2036), Driven by Novel Therapies and Expanding Treatment Landscape | DelveInsight

TBI-1301INT230-6Positive

AI Analysis

Summary

Market analysis report projects the soft tissue sarcoma market across 7 major markets will grow at a CAGR of 7.9% from 2026-2036, driven by increased disease recognition, improved diagnostics, and development of novel therapies including TBI-1301 and INT230-6.

Importance:2/10

Sentiment:

0.30

soft tissue sarcomamarket analysisnovel therapiestreatment landscape

Read the original article

Published by PR Newswire Biotech on July 15, 2026 2:31 PM

Read Original